CD8A and ovarian cancer: To determine the effect of ESRP1 in the tumor immune microenvironment in vivo in ovarian cancer, ESRP1-overexpressing ovarian cancer cells or empty vector-transfected cells were subcutaneously injected into mice, and infiltrating CD8+ T cells in tumor nodules were observed [14].